Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

CINACALCET PSK™ tablets 30mg, 28pcs

🔥 4 items sold in last 3 hours
23 people are viewing this product
  • Cinacalcet Psk™ Tablets 30Mg, 28Pcs Buy Online 4
  • Cinacalcet Psk™ Tablets 30Mg, 28Pcs Buy Online 6
  • Cinacalcet Psk™ Tablets 30Mg, 28Pcs Buy Online 8
Active Ingredient:

Manufacturer:

$538.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

L-THYROXINE tablets 100mcg, 50pcs

$7.00
Add to cart

L-THYROXINE tablets 50mcg, 50pcs

$7.00
Add to cart

Analogs of CINACALCET PSK™

L-THYROXINE tablets 100mcg, 50pcs

$7.00
Add to cart

L-THYROXINE tablets 50mcg, 50pcs

$7.00
Add to cart

L-THYROXINE BERLIN CHEMIE™ tablets 100mcg, 100pcs

$10.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 100mcg, 50pcs

$8.00
Add to cart

Table of Contents

CINACALCET PSK™ 30mg Tablets Buy Online

Understanding Cinacalcet

Maintaining healthy calcium levels is crucial for overall well-being. Cinacalcet plays a vital role in managing conditions affecting calcium regulation, offering a targeted approach to a complex medical challenge.

What is Cinacalcet?

Cinacalcet is a calcium-sensing receptor (CaSR) agonist. It works by modifying the way your body senses and responds to calcium levels. This action influences the production of parathyroid hormone (PTH), a hormone which regulates calcium.

The primary mechanism involves increasing the sensitivity of the calcium-sensing receptor in the parathyroid gland. This heightened sensitivity leads to a reduction in parathyroid hormone secretion. Lower PTH levels help to regulate calcium levels in the blood, thereby addressing the root cause of several related conditions.

Dosage is determined by a physician based on individual needs and response. It’s usually administered orally, with adjustments made according to blood calcium and PTH levels. Careful monitoring is essential to optimize treatment.

Pros

  • Effective in managing hyperparathyroidism: Cinacalcet effectively lowers elevated parathyroid hormone levels.
  • Improves calcium levels: By regulating PTH, it helps maintain healthy calcium levels in the blood.
  • Reduces the risk of complications: Managing calcium and PTH levels can minimize the risk of complications associated with hyperparathyroidism.

Cons

  • Hypocalcemia (low blood calcium): This is a potential risk, requiring monitoring of calcium levels.
  • Nausea and vomiting: These are common side effects, often resolving with continued use.
  • Muscle cramps: Muscle discomfort can occur, often manageable with adjustments to treatment.

Important Considerations

Close medical supervision is necessary throughout the treatment process. Regular monitoring of calcium and PTH levels is crucial to ensure safe and effective use. Individual responses vary, necessitating personalized treatment plans.

Conclusion

Cinacalcet offers a significant therapeutic advantage in managing specific calcium-related disorders. Its precise mechanism and targeted action provide an effective means of regulating calcium and PTH levels, thereby improving patient outcomes. However, close medical monitoring is essential to mitigate potential side effects and optimize treatment efficacy.

What is Cinacalcet?

Cinacalcet is a highly specialized medication categorized as a calcium-sensing receptor (CaSR) agonist. Its primary function revolves around the intricate regulation of calcium and parathyroid hormone (PTH) levels within the body. Understanding its role requires appreciating the delicate balance these elements maintain in overall health.

Specifically, Cinacalcet acts by modifying the sensitivity of the CaSR, located primarily in the parathyroid glands. This receptor plays a crucial role in sensing calcium levels in the bloodstream. By influencing CaSR activity, Cinacalcet directly impacts the production and release of PTH. This hormone is vital in controlling the amount of calcium absorbed from the intestines and released from bones. An imbalance in PTH can lead to various health complications.

The clinical implications of this mechanism are significant. In conditions where PTH levels are abnormally high, leading to elevated blood calcium, Cinacalcet offers a targeted therapeutic approach. By lowering PTH secretion, it helps restore the balance, preventing potential complications associated with hypercalcemia. The precise nature of its action makes it a valuable tool in managing specific endocrine disorders.

Therefore, Cinacalcet isn’t a simple calcium regulator; it’s a sophisticated modulator of a complex hormonal pathway. Its efficacy stems from its ability to address the underlying cause of imbalances, rather than simply treating the symptoms. This targeted mechanism distinguishes it from other therapies.

Mechanism of Action

Cinacalcet’s therapeutic effect hinges on its unique interaction with the body’s calcium-regulating system. Unlike medications that directly influence calcium levels, Cinacalcet operates by targeting the calcium-sensing receptor (CaSR), a protein embedded in the membranes of parathyroid cells.

By binding to and activating the CaSR, Cinacalcet essentially enhances the receptor’s sensitivity to extracellular calcium. This increased sensitivity translates to a more effective signaling pathway within the parathyroid gland. The result is a significant reduction in the secretion of parathyroid hormone (PTH).

The decrease in PTH levels is the key to Cinacalcet’s therapeutic action. PTH plays a critical role in maintaining calcium homeostasis. When PTH levels are elevated, as often seen in secondary hyperparathyroidism, it can lead to excessive bone resorption and increased calcium levels in the blood. Cinacalcet helps to counteract this by directly reducing PTH production.

This targeted mechanism offers several advantages. It allows for a more precise and controlled regulation of calcium and PTH levels, minimizing the risk of adverse effects often associated with less specific therapies. The precise modulation of PTH secretion contributes to the drug’s effectiveness in managing various conditions associated with calcium and bone metabolism disorders.

Furthermore, the mechanism’s specificity makes Cinacalcet a valuable tool in managing hypercalcemia and its associated complications. By addressing the root cause of the imbalance—excessive PTH—Cinacalcet offers a more comprehensive therapeutic approach compared to simply managing the elevated calcium levels. This targeted approach helps to prevent long-term complications often associated with persistent hyperparathyroidism.

Dosage and Administration

The administration of Cinacalcet is strictly under the guidance and supervision of a healthcare professional. Dosage is not standardized and is carefully tailored to the individual patient’s needs and response to treatment. This personalized approach is crucial for achieving optimal therapeutic outcomes while minimizing potential side effects.

Typically, Cinacalcet is administered orally, in tablet form. The initial dose is usually established based on factors such as the severity of the underlying condition, the patient’s overall health, and other medications they may be taking. Careful monitoring of blood calcium and parathyroid hormone (PTH) levels is paramount in determining the appropriate starting dose.

Following the initial dose, subsequent adjustments are made based on regular monitoring of serum calcium and PTH levels. These parameters are carefully assessed to gauge the effectiveness of the treatment and to ensure that the dosage remains within the therapeutic range. Titration of the dose—the process of gradually increasing or decreasing the dosage—is often employed to optimize treatment efficacy.

The frequency of dosage adjustments varies depending on individual responses. Some patients may require adjustments every few weeks, while others may remain on a stable dose for extended periods. This individualized approach is a hallmark of responsible Cinacalcet therapy, ensuring both safety and effectiveness. Regular blood tests are therefore an essential component of treatment management.

It is crucial to emphasize that patients should never adjust their dosage independently. Any changes to the prescribed regimen must be made in consultation with their physician. Self-adjusting the dosage can lead to serious health consequences, including dangerously low calcium levels (hypocalcemia) or insufficient control of PTH. Therefore, strict adherence to the prescribed regimen is essential for achieving the desired therapeutic effects and minimizing risks.

Benefits of Using Cinacalcet

Cinacalcet offers a targeted approach to managing conditions characterized by imbalances in calcium and parathyroid hormone (PTH) regulation. Its primary benefit lies in its ability to effectively control elevated PTH levels, a key factor in several endocrine disorders. This precise mechanism of action distinguishes it from other treatments that might address symptoms without targeting the underlying cause.

One significant advantage is its efficacy in reducing the symptoms associated with hyperparathyroidism. By lowering excessive PTH, Cinacalcet helps alleviate the consequences of this hormonal imbalance, including elevated blood calcium levels (hypercalcemia) and the associated bone problems. This targeted approach leads to noticeable improvements in patient well-being.

Furthermore, the use of Cinacalcet can contribute to improved bone health. By controlling PTH, it mitigates the excessive bone breakdown (bone resorption) that often accompanies hyperparathyroidism. This protective effect on bone structure is crucial in preserving bone density and reducing the risk of fractures, especially in individuals with weakened bones.

Beyond these direct effects, Cinacalcet can offer indirect benefits by reducing the risk of cardiovascular complications frequently associated with hypercalcemia. Maintaining healthy calcium levels is essential for cardiovascular health, and Cinacalcet’s ability to regulate calcium contributes to overall cardiovascular well-being. This contributes to improved quality of life for patients.

In summary, the benefits of Cinacalcet extend beyond the simple lowering of PTH and calcium levels. It offers a comprehensive approach to managing hyperparathyroidism, improving bone health, and reducing the risk of associated cardiovascular complications. This multi-faceted approach contributes significantly to enhanced patient outcomes and improved quality of life.

Pros

  • Effective PTH Reduction: Cinacalcet’s primary advantage is its ability to significantly lower elevated parathyroid hormone (PTH) levels. This targeted action addresses the root cause of hyperparathyroidism, leading to improved calcium regulation and overall health improvements. The direct impact on PTH distinguishes it from treatments addressing only symptoms.
  • Improved Calcium Homeostasis: By controlling PTH, Cinacalcet helps restore balance to the body’s calcium levels. This is crucial for preventing complications associated with both hypercalcemia (high calcium) and hypocalcemia (low calcium), conditions that can have serious consequences. Maintaining calcium balance is critical for numerous bodily functions.
  • Enhanced Bone Health: The reduction in PTH brought about by Cinacalcet helps protect bone health. Excessive PTH can lead to bone loss and increased fracture risk. Cinacalcet’s ability to mitigate this effect is a significant benefit, particularly for patients already at risk of bone fragility. Protecting bone density is vital for long-term well-being.
  • Potential Cardiovascular Benefits: Maintaining healthy calcium levels is crucial for cardiovascular health. By regulating calcium, Cinacalcet may indirectly contribute to cardiovascular well-being, although further research is ongoing to fully define this association. The link between calcium balance and cardiovascular health is well-established.
  • Targeted Therapy: Unlike some broader-acting medications, Cinacalcet offers a targeted approach, focusing specifically on the parathyroid glands and PTH regulation. This precise mechanism of action minimizes potential side effects associated with less targeted therapies. Specificity in treatment often improves patient outcomes.

Potential Side Effects

While Cinacalcet offers significant therapeutic benefits, it’s crucial to be aware of potential side effects. These are not experienced by all patients, and their severity can vary considerably. Careful monitoring by a healthcare professional is essential to manage any adverse reactions effectively.

One of the most commonly reported side effects is hypocalcemia, or low blood calcium levels. This is a direct consequence of Cinacalcet’s mechanism of action, which reduces parathyroid hormone (PTH) and subsequently calcium levels. Regular monitoring of calcium levels is crucial to detect and manage hypocalcemia promptly.

Gastrointestinal issues, such as nausea and vomiting, are also relatively common. These side effects are often mild and may resolve spontaneously as the body adjusts to the medication. However, more severe gastrointestinal distress may necessitate dose adjustments or alternative treatment strategies.

Muscle cramps and muscle spasms are other potential side effects, often related to changes in calcium balance. These symptoms can be uncomfortable, but they are usually manageable with appropriate adjustments to the medication dosage or through supportive measures like increased calcium intake. In some cases, additional medications might be required.

Less frequently reported side effects include fatigue, dizziness, and headache. These symptoms are usually mild and transient, resolving without intervention. However, persistent or severe symptoms warrant immediate medical attention. It is important to communicate any new or worsening symptoms to your doctor.

Finally, it’s vital to remember that individual responses to Cinacalcet can vary considerably. What might be a minor side effect for one patient could be more significant for another. Open communication with your doctor is essential for managing any side effects effectively and ensuring that you receive the optimal treatment.

Cons

  • Risk of Hypocalcemia: A significant potential drawback is the risk of developing hypocalcemia (low blood calcium). This is because Cinacalcet’s mechanism of action directly reduces parathyroid hormone (PTH), which plays a key role in regulating calcium levels. Careful monitoring of calcium levels is essential to mitigate this risk. Early detection and management are crucial.
  • Gastrointestinal Distress: Nausea and vomiting are commonly reported side effects. While often mild and transient, these gastrointestinal symptoms can be uncomfortable and may necessitate dose adjustments or alternative management strategies in some individuals. The severity of these effects varies significantly between patients.
  • Musculoskeletal Symptoms: Muscle cramps and spasms are potential side effects linked to the alteration of calcium balance. These symptoms can range from mild discomfort to significant pain and can impact daily activities. Appropriate management strategies may include dietary changes or supplemental medications.
  • Drug Interactions: Cinacalcet may interact with other medications, potentially affecting their effectiveness or increasing the risk of side effects. It’s crucial to inform your healthcare provider about all medications you’re taking, including over-the-counter drugs and supplements. Careful consideration of potential interactions is paramount.
  • Individual Variability: The response to Cinacalcet can vary significantly among patients. What might be a minor side effect for one person could be more pronounced or bothersome for another. This variability underscores the importance of close medical supervision and personalized treatment plans. Individualized care is essential for optimizing outcomes.
  • Cinacalcet Psk™ Tablets 30Mg, 28Pcs Buy Online 10
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Cinacalcet Psk™ Tablets 30Mg, 28Pcs Buy Online 12
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Cinacalcet Psk™ Tablets 30Mg, 28Pcs Buy Online 14
    [Medical reviewer]

    Dr. Lewis Rappaport is a highly experienced and respected cardiologist who serves as a salaried specialist and consultant for the licensed online pharmacy, RxPulsar.com. With over 30 years of practice...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “CINACALCET PSK™ tablets 30mg, 28pcs”

Your email address will not be published. Required fields are marked

Similar products

PREDNOL-L™ lyophilisate for injection solution 250mg, ampoule 1pc + solvent 4ml, ampoule 1pc

$28.00
Add to cart

PREDNISOLONE™ ointment 0.5% (10g), 1pc

$5.00
Add to cart

OXYTOCIN solution for IV/IM injection 5IU/ml (1ml), 10pcs

$8.00
Add to cart

OXYTOCIN-RICHTER™ solution for IV infusion/IM injection 5IU/ml (1ml), 5pcs

$13.00
Add to cart

MINIRIN MELT™ lyophilisate tablets 120mcg, 30pcs

$191.00
Add to cart

MINIRIN MELT™ lyophilisate tablets 60mcg, 30pcs

$95.00
Add to cart

MINIRIN™ tablets 0.1mg, 30pcs

$52.00
Add to cart

MINIRIN™ tablets 0.2mg, 30pcs

$104.00
Add to cart

DOSTINEX™ tablets 0.5mg, 2pcs

$60.00
Add to cart

DOSTINEX™ tablets 0.5mg, 8pcs

$183.00
Add to cart

DIFERELIN™ lyophilisate for prolonged-release suspension for i/m injection 3.75mg, vial 1pc

$366.00
Add to cart

DESMOPRESSIN tablets 0.2mg, 30pcs

$91.00
Add to cart

DESMOPRESSIN tablets 0.1mg, 30pcs

$51.00
Add to cart

CHORIONIC GONADOTROPIN lyophilisate for injection 1000IU, 5pcs + solvent 1ml, 5pcs

$168.00
Add to cart

CHORIONIC GONADOTROPIN lyophilisate for intramuscular injection solution 5000IU, 5pcs

$595.00
Add to cart

BUSERELIN-DEPO™ lyophilisate for prolonged-release suspension for i.m. injection 3.75mg, vial 1pc

$249.00
Add to cart

BUSERELIN-LONG™ lyophilisate for prolonged-release suspension for i.m. injection 3.75mg, vial 1pc

$264.00
Add to cart

BERGOLAK™ tablets 0.5mg, 2pcs

$39.00
Add to cart

BERGOLAK™ tablets 0.5mg, 8pcs

$110.00
Add to cart

AGALATES™ tablets 0.5mg, 2pcs

$72.00
Add to cart

AGALATES™ tablets 0.5mg, 8pcs

$144.00
Add to cart
Select your currency